PREDIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.805
EU - Europa 24.790
AS - Asia 13.972
SA - Sud America 1.806
AF - Africa 327
OC - Oceania 164
Continente sconosciuto - Info sul continente non disponibili 20
Totale 68.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.299
IT - Italia 12.066
GB - Regno Unito 4.840
SG - Singapore 4.693
CN - Cina 4.275
HK - Hong Kong 2.035
SE - Svezia 1.710
DE - Germania 1.679
BR - Brasile 1.394
UA - Ucraina 772
VN - Vietnam 708
RU - Federazione Russa 697
FR - Francia 673
FI - Finlandia 592
TR - Turchia 544
NL - Olanda 322
IN - India 317
KR - Corea 308
BG - Bulgaria 300
ID - Indonesia 270
CA - Canada 264
JP - Giappone 177
IE - Irlanda 174
CH - Svizzera 143
ES - Italia 133
AU - Australia 128
AR - Argentina 126
MX - Messico 122
PL - Polonia 118
ZA - Sudafrica 109
IR - Iran 95
BD - Bangladesh 87
EC - Ecuador 84
LT - Lituania 84
BE - Belgio 78
BZ - Belize 74
AT - Austria 73
EG - Egitto 73
IQ - Iraq 70
PK - Pakistan 67
DK - Danimarca 65
MY - Malesia 57
CZ - Repubblica Ceca 54
CO - Colombia 45
VE - Venezuela 43
RO - Romania 37
NZ - Nuova Zelanda 36
PT - Portogallo 34
PE - Perù 33
TH - Thailandia 33
CL - Cile 29
MA - Marocco 29
IL - Israele 27
PY - Paraguay 27
SA - Arabia Saudita 27
GR - Grecia 26
TW - Taiwan 26
PH - Filippine 24
UZ - Uzbekistan 23
HU - Ungheria 19
TN - Tunisia 19
DZ - Algeria 17
KE - Kenya 15
RS - Serbia 15
UG - Uganda 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 13
EU - Europa 13
SM - San Marino 13
ET - Etiopia 12
UY - Uruguay 12
NG - Nigeria 11
DO - Repubblica Dominicana 10
JO - Giordania 10
NO - Norvegia 10
KZ - Kazakistan 9
KW - Kuwait 8
LB - Libano 8
PA - Panama 8
BO - Bolivia 7
LK - Sri Lanka 7
MK - Macedonia 7
MT - Malta 7
AM - Armenia 6
CR - Costa Rica 6
EE - Estonia 6
HN - Honduras 6
NP - Nepal 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
GY - Guiana 5
OM - Oman 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
GH - Ghana 4
GT - Guatemala 4
HR - Croazia 4
Totale 68.814
Salva come PNG Salva come JPEG
Città #
Southend 3.321
Singapore 3.198
Santa Clara 3.138
Ashburn 2.287
Fairfield 2.254
Hong Kong 1.982
Chandler 1.624
Woodbridge 1.600
Houston 1.552
Hefei 1.414
Jacksonville 1.358
Dearborn 1.130
Nyköping 888
Milan 877
Rome 873
Ann Arbor 859
Seattle 838
London 825
Wilmington 814
Beijing 719
Cambridge 686
Los Angeles 429
New York 394
Munich 377
Naples 368
Princeton 325
Bologna 316
Helsinki 307
Sofia 285
Seoul 280
Modena 265
Eugene 253
San Diego 251
Palermo 240
Chicago 237
Ho Chi Minh City 232
The Dalles 223
Redwood City 217
Jakarta 214
Shanghai 213
Moscow 210
Turin 209
Izmir 207
Buffalo 199
Bremen 187
San Jose 187
Bari 163
Council Bluffs 144
Frankfurt am Main 144
Florence 141
Hanoi 141
São Paulo 137
Catania 135
Dublin 134
Dallas 128
Padova 121
Verona 109
Columbus 107
Boardman 104
Parma 104
Tokyo 98
Fremont 97
Des Moines 94
Salt Lake City 85
Albuquerque 78
Las Vegas 78
Johannesburg 76
Toronto 76
Belize City 73
Genoa 72
Warsaw 71
Falls Church 70
Phoenix 69
Guangzhou 66
Brescia 65
Tampa 65
Nuremberg 62
Dong Ket 61
Pescara 60
Nanjing 59
Turku 59
Montreal 57
Redondo Beach 55
Kent 52
Norwalk 52
Denver 51
Brooklyn 49
Cagliari 49
Poplar 49
Reggio Emilia 49
Cairo 48
Rio de Janeiro 47
Amsterdam 46
Atlanta 46
Paris 45
Chennai 44
Ankara 42
Perugia 42
Brussels 41
Orem 41
Totale 43.113
Salva come PNG Salva come JPEG
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.503
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.101
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.066
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 839
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 704
Gestione del Covid-19 in età pediatrica: documento di consenso 695
Effetti degli interferenti endocrini su crescita e sviluppo puberale 639
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 615
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 522
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 469
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 434
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 404
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 389
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 372
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 369
High basal serum allopregnanolone levels in overweight girls 358
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 343
Childhood obesity and environmental pollutants: a dual relationship 340
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 338
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 338
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 334
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 332
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 329
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 326
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 324
Low serum allopregnanolone levels in girls with precocious pubarche 321
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 321
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 320
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 320
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 319
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 317
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 306
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 304
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 303
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 303
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 302
L’ipercolesterolemia familiare: terapia farmacologica 299
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 299
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 293
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 291
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 288
Approaches to dyslipidemia treatment in children and adolescents 285
Brain-derived neurotrophic factor and epilepsy: a systematic review 275
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 265
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 264
COVID-19 and Type 1 Diabetes: Concerns and Challenges 262
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 256
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 256
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 256
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 256
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 254
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 254
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 254
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 254
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 251
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 250
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 250
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 247
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 246
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 246
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 245
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 243
Obesity in pediatric age: The analysis of genomic rearrangements 243
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 241
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 241
Hypercholesterolemia in Childhood 238
Rhabdomyoma of a rare type in a child: Case report and literature review 236
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 235
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 234
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 234
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 233
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 233
Confocal microscopy: Improving our understanding of nevogenesis 232
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 231
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 231
Novel insights on the treatment of hypercholesterolemia 230
Endocrine Disrupting Chemicals and Type 1 Diabetes 230
Low-density lipoprotein oxidizability in children with chronic renal failure 226
High serum allopregnanolone levels in girls with precocious puberty 225
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 225
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 224
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 223
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 223
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 222
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 222
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 222
Iper CPKemia, non solo miopatie 219
Evaluation and management of hyperlipidemia in children and adolescents. 217
Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus 215
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 215
Can inflammatory marker levels help in detecting early complications of childhood obesity? 214
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 213
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 212
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 212
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 212
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 211
Pharmacological treatment of obesity in children and adolescents: Present and future 209
Gli interferenti endocrini 209
A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes 209
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 207
Totale 35.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.176 0 0 0 0 0 541 952 630 405 694 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202611.910 1.631 972 2.031 2.832 3.901 543 0 0 0 0 0 0
Totale 69.708